Shanxi Jinjin

Shanxi Jinjin Pharmaceutical is a specialized pharmaceutical company based in China that focuses on the development and manufacture of steroid hormone active pharmaceutical ingredients (APIs). Established in 2003, the company has become a prominent global supplier of mineralocorticoid receptor antagonists, including spironolactone and eplerenone. Their manufacturing operations are centered in Yuncheng, Shanxi, where they operate facilities compliant with international Good Manufacturing Practice (GMP) standards. The company's product portfolio primarily addresses therapeutic needs in cardiovascular health, endocrinology, and reproductive medicine. In addition to its core API business, Shanxi Jinjin provides contract manufacturing and development services for complex steroidal intermediates. The firm is recognized for its robust chemical synthesis capabilities and its significant export presence in international regulated markets.